RxDoctor Payments Data

Richard Steslow, DO

Family Medicine · Aurora, ILNPI 1306980743

Payments from drug & device makers

$1,656in general payments, 2019–2025

Across 44 payments — averaging $37.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$409
  • Kerecis Limited$202
  • Misonix Inc$170
  • Novo Nordisk$154
  • Organogenesis Inc.$140
  • Integra Lifesciences Corporation$98
  • plus $483 from 14 others

What the payments were for

  • Food & beverage$1,656100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,656 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$115,234
Medicare patients
173
Services billed
1,248

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide14$13,000
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen125$5,079
VyvanseLisdexamfetamine Dimesylate12$4,322
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$2,790
Gabapentin85$1,855
Albuterol Sulfate HfaAlbuterol Sulfate59$1,560
Irbesartan50$1,426
Rosuvastatin Calcium111$1,353
Oxycodone Hcl36$1,218
Testosterone Cypionate13$1,180
Propranolol Hcl ErPropranolol Hcl14$1,118
Metoprolol Succinate39$1,017
Losartan Potassium101$1,012
Ezetimibe31$999
Atorvastatin Calcium118$974

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$154$13,00014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Aurora

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →